Detailed explanation of the functions and purchasing channels of the milk-reducing drug cabergoline: an essential guide for breastfeeding women

Cabergoline (Cabergoline) is a dopamine receptor agonist, mainly used to inhibit postpartum milk secretion (milk return) and treat hyperprolactinemia and pituitary prolactinoma. For many lactating women, cabergoline is an efficient and convenient milk-returning drug, but its specific effects and purchase channels may not be known to everyone. This article will provide you with a detailed analysis of cabergoline’s mechanism of action, applicable groups, and purchasing methods.

Cabergoline inhibits the secretion of prolactin (PRL) from the anterior pituitary gland by activating dopamineD2 receptors, thereby reducing milk secretion. Compared with traditional methods of reintroducing milk (such as gradually reducing the frequency of breastfeeding), cabergoline can quickly and effectively suppress lactation, reducing breast tenderness and the risk of mastitis. It usually only takes 1-2 times to achieve the desired milk return effect, and is especially suitable for women who are unable to breastfeed due to medical reasons or who need to stop lactation immediately.

In terms of purchase channels, cabergoline is a prescription drug and must be purchased at regular hospitals or pharmacies with a doctor's prescription. This drug can usually be prescribed by the obstetrics and gynecology or endocrinology departments of domestic hospitals. In addition, some regular online pharmacies may also provide cabergoline, but when purchasing, you need to ensure that the platform has legal qualifications and check the approval number and expiration date of the drug to avoid purchasing fake and shoddy products.

It should be noted that although cabergoline is effective, it is not suitable for all people. This drug should be avoided in patients who are allergic to cabergoline, have valvular heart disease, or have uncontrolled high blood pressure. In addition, cabergoline inhibits breast milk secretion, so it is not recommended to continue breastfeeding after taking the drug. If women plan to breastfeed again in the future, they need to communicate with their doctor in advance to develop an appropriate medication plan.

Reference materials:https://my.clevelandclinic.org/health/drugs/20863-cabergoline-tablets